A. Ewing

Reproducible and Characterized Method for Ponatinib Encapsulation into Biomimetic Lipid Nanoparticles as a Platform for Multi-Tyrosine Kinase-Targeted Therapy.

J. Yustein, Assaf Zinger, E. Tasciotti, 2020, ACS applied bio materials.

Tyrosine kinase inhibitor-loaded biomimetic nanoparticles as a treatment for osteosarcoma

J. Yustein, M. Agostini, E. De Rosa, 2022, Cancer Nanotechnology.

In vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice.

M. Ferrari, I. Fidler, R. Nieves-Alicea, 2010, International journal of pharmaceutics.